Sanofi Saglik Urunleri Limited Sirketi
Sanofi Sağlık Ürünleri Limited Şirketi, headquartered in Turkey, is a prominent player in the pharmaceutical and healthcare industry. Established in 2004, the company has made significant strides in providing innovative health solutions across various operational regions, including Europe and the Middle East.
Specialising in prescription medicines, vaccines, and consumer healthcare products, Sanofi is recognised for its commitment to research and development, which drives the creation of unique therapies tailored to meet patient needs. With a strong market position, Sanofi has achieved notable milestones, including advancements in diabetes care and rare diseases, solidifying its reputation as a leader in the healthcare sector.
Through its dedication to improving health outcomes, Sanofi Sağlık Ürünleri Limited Şirketi continues to play a vital role in enhancing the quality of life for patients worldwide.
+60 vs industry average
Sanofi Saglik Urunleri Limited Sirketi’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Sanofi Saglik Urunleri Limited Sirketi?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Sanofi Saglik Urunleri Limited Sirketi yet.
Sanofi Saglik Urunleri Limited Sirketi's reported carbon emissions
Sanofi Saglik Urunleri Limited Sirketi, headquartered in Turkey (TR), currently does not report specific carbon emissions data for the most recent year. As a current subsidiary of Sanofi, the company inherits its climate commitments and initiatives from its parent organisation.
Sanofi has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded to Sanofi Saglik Urunleri Limited Sirketi at a level 1 relationship. However, specific reduction targets or achievements for this subsidiary have not been disclosed.
The absence of direct emissions data highlights the importance of Sanofi's overarching climate strategy, which aims to address carbon emissions across its operations. As part of the broader Sanofi corporate family, the company is aligned with industry standards and practices aimed at reducing environmental impact and enhancing sustainability.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sanofi Saglik Urunleri Limited Sirketi’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Sanofi Saglik Urunleri Limited Sirketi yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
Inherited from SanofiThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Sanofi Saglik Urunleri Limited Sirketi yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project